These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23239742)

  • 1. The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent.
    Brim RL; Miller FG
    J Med Ethics; 2013 Nov; 39(11):703-7. PubMed ID: 23239742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.
    Miller FG; Colloca L
    Theor Med Bioeth; 2011 Aug; 32(4):229-43. PubMed ID: 21479794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethics in psychiatric research].
    Helmchen H
    Psychiatr Prax; 2014 Jul; 41 Suppl 1():S31-7. PubMed ID: 24983573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thinking clearly about the FIRST trial: addressing ethical challenges in cluster randomised trials of policy interventions involving health providers.
    Horn AR; Weijer C; Hey SP; Brehaut J; Fergusson DA; Goldstein CE; Grimshaw J; Taljaard M
    J Med Ethics; 2018 Sep; 44(9):593-598. PubMed ID: 29703860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson's Disease.
    Polgar S; Mohamed S
    J Parkinsons Dis; 2019; 9(3):565-574. PubMed ID: 31282423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled trials as minimal risk: an ethical analysis.
    Morris MC; Nelson RM
    Crit Care Med; 2007 Mar; 35(3):940-4. PubMed ID: 17255879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering the ethics of sham interventions in an era of emerging technologies.
    Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL
    Surgery; 2015 Apr; 157(4):801-10. PubMed ID: 25704427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed consent and clinical trials: where is the placebo effect?
    Blease CR; Bishop FL; Kaptchuk TJ
    BMJ; 2017 Feb; 356():j463. PubMed ID: 28159769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loopholes in the Research Ethics System? Informed Consent Waivers in Cluster Randomized Trials with Individual-Level Intervention.
    London AJ; Taljaard M; Weijer C
    Ethics Hum Res; 2020 Nov; 42(6):21-28. PubMed ID: 33136332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture trials and informed consent.
    Miller FG; Kaptchuk TJ
    J Med Ethics; 2007 Jan; 33(1):43-4. PubMed ID: 17209110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.
    Banja JD; Dunlop B
    Am J Bioeth; 2009 Aug; 9(8):39-41. PubMed ID: 19998159
    [No Abstract]   [Full Text] [Related]  

  • 13. Informed consent in cluster randomised trials: new and common ethical challenges.
    Lignou S
    J Med Ethics; 2018 Feb; 44(2):114-120. PubMed ID: 28780528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised placebo-controlled trials of surgery: ethical analysis and guidelines.
    Savulescu J; Wartolowska K; Carr A
    J Med Ethics; 2016 Dec; 42(12):776-783. PubMed ID: 27777269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Details of risk-benefit communication in informed consent documents for phase I/II trials.
    Kahrass H; Bossert S; Schürmann C; Strech D
    Clin Trials; 2021 Feb; 18(1):71-80. PubMed ID: 33231107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consenting for current genetic research: is Canadian practice adequate?
    Jaitovich Groisman I; Egalite N; Godard B
    BMC Med Ethics; 2014 Nov; 15():80. PubMed ID: 25410958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain.
    Hughes J; Greville-Harris M; Graham CA; Lewith G; White P; Bishop FL
    J Med Ethics; 2017 Dec; 43(12):867-870. PubMed ID: 28663259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do informed consent documents matter?
    Resnik DB
    Contemp Clin Trials; 2009 Mar; 30(2):114-5. PubMed ID: 18977313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
    Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Must research benefit human subjects if it is to be permissible?
    Wikler D
    J Med Ethics; 2017 Feb; 43(2):114-117. PubMed ID: 27573151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.